Optiscan has been featured in the ASX Briefs podcast where CEO and Managing Director Dr. Camile Farah discusses the major milestones being achieved - and those yet to come - in this landmark year for the company.
The conversation focuses on Optiscan’s latest regulatory milestone with the U.S. FDA dossier submission for InSpecta, why the US market matters so much, the unique dynamics of the veterinary medicine market, and how it is helping pave the way for future submissions.
Camile also discusses the world-first in-human head and neck cancer study at St John of God Murdoch Hospital which is leveraging Optiscan’s InVue and InForm devices, as well as the company’s partnership with Australian Clinical Labs and how tele pathology could impact medical imaging in the future.
The conversation reflects the dynamic stage Optiscan is in right now, and what's to come.
Listen to the full episode here.
